VeriMomIst sh-tetrapeptide-38 trifluoroacetate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
Related ingredients
Frequently asked questions
- Ist sh-tetrapeptide-38 trifluoroacetate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
- Ist sh-tetrapeptide-38 trifluoroacetate während des Stillens sicher?
- No data found indicating systemic exposure, transfer into breastmilk, or lactation toxicity. Given the lack of reproductive or developmental hazard data and expected low dermal absorption of short peptides, exposure via breastmilk is considered negligible for topical cosmetic use (sources searched: SCCS/CIR, PubMed, PubChem, CosIng, ECHA).
- Ist sh-tetrapeptide-38 trifluoroacetate sicher für Babyhaut?
- No infant‑specific reproductive or toxicity data found. Mechanistic/toxic effects not identified. Exposure rating increased by +1 for baby skin relative to adults because infants have an immature skin barrier and higher surface‑area‑to‑weight ratio; although adult dermal absorption is considered negligible, infant exposure is plausibly low but measurable for topical application. No evidence found of specific hazard to infants aged 0–3 years (sources searched: PubMed, CosIng, ECHA, PubChem, EWG).
- Wie bewertet VeriMom sh-tetrapeptide-38 trifluoroacetate?
- VeriMom bewertet sh-tetrapeptide-38 trifluoroacetate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu sh-tetrapeptide-38 trifluoroacetate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu sh-tetrapeptide-38 trifluoroacetate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.